🇺🇸 FDA
Patent

US 6794373

Contraceptive methods using benzimidazolones

expired A61KA61K31/415A61K31/535

Quick answer

US patent 6794373 (Contraceptive methods using benzimidazolones) held by Ligand Pharmaceuticals Incorporated expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/415, A61K31/535, A61K31/54, A61K31/56